Top

12-03-2025 | Global Health Services Research

Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer

Authors: J. Asher Jenkins, MD, Mohamed R. Aly, MBBCh, Juan Maria Farina, MD, Ahmed Khedr, MBBS, Elisa Bass, BA, Blake Langlais, MS, Cecilia Benz, MD, Dawn E. Jaroszewski, MD, Staci Beamer, MD, Samine Ravanbakhsh, MD, Vinicius Ernani, MD, Jonathan D’Cunha, MD, Pedro Augusto Reck Dos Santos, MD

Published in: Annals of Surgical Oncology

Abstract

Background

Treatment of non-small cell lung cancer (NSCLC) remains challenging; 5-year survival is as low as 24% for resectable disease. However, the outlook for stage IA NSCLC is favorable, with 5-year survival exceeding 74% and with surgery often being curative. Despite this positive prognosis, low socioeconomic status has been shown to correlate with nonstandard treatment and worse overall survival specifically in stage IA. This study sought to examine income-based disparities in postsurgical survival which has yet to be discussed in the current literature.

Methods

The National Cancer Database was retrospectively queried from 2004 to 2017 to identify patients with pathological stage IA NSCLC following surgical resection; survival/patient characteristics were analyzed by income quartiles and eras (2004–2007, 2008–2012, and 2013–2017). Kaplan-Meier methods and multivariable Cox hazard modeling were used to estimate survival and construct hazard ratios, respectively.

Results

Inclusion criteria identified 138,219 patients. Overall, a stepwise decrease in 5-year survival was observed as income quartile decreased (Q4: 72.0%; Q3: 67.8%; Q2: 66.1%; Q1: 64.2%). Hazard modeling implicated income level as an independent predictor of mortality; patients of the lowest income quartile exhibited a hazard ratio of 1.26 (95% confidence interval 1.21–1.31; p < 0.001) relative to the highest. Although overall survival increased within each income quartile over consecutive eras, income-based survival disparities continued to be observed.

Conclusions

Lower-income patients with stage IA NSCLC display elevated mortality risk over 5 years than higher-income patients despite receiving potentially curative surgery, with income being an independent risk-factor. This difference may also be attributed to stacked risk-factors in lower-income patients.

American Cancer Society. Cancer Facts & Figures 2024. Web: American Cancer Society; 2024.

Morgensztern D, Du L, Waqar SN, et al. Adjuvant chemotherapy for patients with T2N0M0 NSCLC. J Thorac Oncol. 2016;11(10):1729–35. https://doi.org/10.1016/j.jtho.2016.05.022.CrossRefPubMedPubMedCentral

Nalluri H, Marmor S, Prathibha S, et al. Evaluating disparities in colon cancer survival in American Indian/Alaskan native patients using the national cancer database. J Racial Ethn Health Disparities. 2023. https://doi.org/10.1007/s40615-023-01706-2.CrossRefPubMed

LaPar DJ, Bhamidipati CM, Harris DA, et al. Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States. Ann Thorac Surg. 2011;92(2):434–9. https://doi.org/10.1016/j.athoracsur.2011.04.048.CrossRefPubMedPubMedCentral

Dalwadi SM, Lewis GD, Bernicker EH, Butler EB, Teh BS, Farach AM. Disparities in the treatment and outcome of stage I non-small-cell lung cancer in the 21st century. Clin Lung Cancer. 2019;20(3):194–200. https://doi.org/10.1016/j.cllc.2018.11.004.CrossRefPubMed

Richards TB, Henley SJ, Puckett MC, et al. Lung cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):5079–99. https://doi.org/10.1002/cncr.31029.CrossRefPubMed

United States Preventative Services Task Force, Krist AH, Davidson KW, et al. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021;325(10):962–970. https://doi.org/10.1001/jama.2021.1117

VGaV VA. The next four decades: the older population in the United States: 2010 to 2050. Current Population Reports, US Census Bureau. 2010;(25-1138)

Altorki N, Wang X, Kozono D, et al. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer. N Engl J Med. 2023;388(6):489–98. https://doi.org/10.1056/NEJMoa2212083.CrossRefPubMedPubMedCentral

10.

Ebner PJ, Ding L, Kim AW, et al. The effect of socioeconomic status on treatment and mortality in non-small cell lung cancer patients. Ann Thorac Surg. 2020;109(1):225–32. https://doi.org/10.1016/j.athoracsur.2019.07.017.CrossRefPubMed

11.

Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F, Byrne MM. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Cancer J. 2014;20(4):237–45. https://doi.org/10.1097/PPO.0000000000000058.CrossRefPubMed

12.

Shah M, Parmar A, Chan KKW. Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007–2016. Cancer Med. 2020;9(10):3407–16. https://doi.org/10.1002/cam4.2978.CrossRefPubMedPubMedCentral

13.

Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario. Canada Cancer. 2010;116(17):4160–7. https://doi.org/10.1002/cncr.25427.CrossRefPubMed

14.

Nissen AP, Vreeland TJ, Teshome M, et al. American college of surgeons commission on cancer standard for curative-intent pulmonary resection. Ann Thorac Surg. 2022;113(1):5–8. https://doi.org/10.1016/j.athoracsur.2021.05.051.CrossRefPubMed

15.

Samayoa AX, Pezzi TA, Pezzi CM, et al. Rationale for a minimum number of lymph nodes removed with non-small cell lung cancer resection: correlating the number of nodes removed with survival in 98,970 patients. Ann Surg Oncol. 2016;23(Suppl 5):1005–11. https://doi.org/10.1245/s10434-016-5509-4.CrossRefPubMed

16.

Evans N 3rd, Grenda T, Alvarez NH, Okusanya OT. Narrative review of socioeconomic and racial disparities in the treatment of early stage lung cancer. J Thorac Dis. 2021;13(6):3758–63. https://doi.org/10.21037/jtd-20-3181.CrossRefPubMedPubMedCentral

17.

Yang R, Cheung MC, Byrne MM, et al. Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer. 2010;116(10):2437–47. https://doi.org/10.1002/cncr.24986.CrossRefPubMed

18.

Hastert TA, Beresford SA, Sheppard L, White E. Disparities in cancer incidence and mortality by area-level socioeconomic status: a multilevel analysis. J Epidemiol Community Health. 2015;69(2):168–76. https://doi.org/10.1136/jech-2014-204417.CrossRefPubMed

19.

Zgodic A, Zahnd WE, Miller DP Jr, Studts JL, Eberth JM. Predictors of lung cancer screening utilization in a population-based survey. J Am Coll Radiol. 2020;17(12):1591–601. https://doi.org/10.1016/j.jacr.2020.06.015.CrossRefPubMed

20.

Lake M, Shusted CS, Juon HS, et al. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up. BMC Cancer. 2020;20(1):561. https://doi.org/10.1186/s12885-020-06923-0.CrossRefPubMedPubMedCentral

21.

Lutfi W, Martinez-Meehan D, Sultan I, et al. Racial disparities in local therapy for early stage non-small-cell lung cancer. J Surg Oncol. 2020;122(8):1815–20. https://doi.org/10.1002/jso.26206.CrossRefPubMed

22.

Kaergaard Starr L, Osler M, Steding-Jessen M, et al. Socioeconomic position and surgery for early-stage non-small-cell lung cancer: a population-based study in Denmark. Lung Cancer. 2013;79(3):262–9. https://doi.org/10.1016/j.lungcan.2012.11.023.CrossRefPubMed

23.

de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–13. https://doi.org/10.1056/NEJMoa1911793.CrossRefPubMed

24.

Leopold C, Park ER, Nekhlyudov L. The impact of the affordable care act on cancer survivorship. Cancer J. 2017;23(3):181–9. https://doi.org/10.1097/PPO.0000000000000263.CrossRefPubMed

25.

Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–48. https://doi.org/10.1007/s10549-019-05340-7.CrossRefPubMed

26.

Ezer N, Mhango G, Bagiella E, Goodman E, Flores R, Wisnivesky JP. Racial disparities in resection of early stage non-small cell lung cancer: variability among surgeons. Med Care. 2020;58(4):392–8. https://doi.org/10.1097/MLR.0000000000001280.CrossRefPubMed

27.

Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341(16):1198–205. https://doi.org/10.1056/NEJM199910143411606.CrossRefPubMed

28.

Khullar OV, Gillespie T, Nickleach DC, et al. Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer: an analysis of more than 90,000 patients from the national cancer data base. J Am Coll Surg. 2015;220(2):156. https://doi.org/10.1016/j.jamcollsurg.2014.10.009.CrossRefPubMed

29.

Lee A, Shah K, Chino F. Assessment of parking fees at national cancer institute-designated cancer treatment centers. JAMA Oncol. 2020;6(8):1295–7. https://doi.org/10.1001/jamaoncol.2020.1475.CrossRefPubMedPubMedCentral

30.

Williamson CG, Richardson S, Ebrahimian S, Kronen E, Verma A, Benharash P. Identifying the origin of socioeconomic disparities in outcomes of major elective operations. Surg Open Sci. 2023;13:66–70. https://doi.org/10.1016/j.sopen.2023.04.001.CrossRefPubMedPubMedCentral

31.

Medbery RL, Gillespie TW, Liu Y, et al. Socioeconomic factors are associated with readmission after lobectomy for early stage lung cancer. Ann Thorac Surg. 2016;102(5):1660–7. https://doi.org/10.1016/j.athoracsur.2016.05.060.CrossRefPubMedPubMedCentral

32.

Potter AL, Kim J, McCarthy ML, et al. Segmentectomy versus lobectomy in the United States: outcomes after resection for first primary lung cancer and treatment patterns for second primary lung cancers. J Thorac Cardiovasc Surg. 2024;167(1):350. https://doi.org/10.1016/j.jtcvs.2023.07.009.CrossRefPubMed

33.

Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the national cancer data base. J Clin Oncol. 2009;27(25):4177–81. https://doi.org/10.1200/JCO.2008.21.7018.CrossRefPubMed

Title: Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer
Authors: J. Asher Jenkins, MD
Mohamed R. Aly, MBBCh
Juan Maria Farina, MD
Ahmed Khedr, MBBS
Elisa Bass, BA
Blake Langlais, MS
Cecilia Benz, MD
Dawn E. Jaroszewski, MD
Staci Beamer, MD
Samine Ravanbakhsh, MD
Vinicius Ernani, MD
Jonathan D’Cunha, MD
Pedro Augusto Reck Dos Santos, MD
Publication date: 12-03-2025
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-025-17107-0

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Chronic Pancreatitis
On-demand webinar

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Podcast | Sexual health in older age

Springer Medicine

Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer

Abstract

Background

Methods

Results

Conclusions

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Podcast | Sexual health in older age

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions